- Parties: The plaintiff was an unnamed pharmaceutical company represented by Mr. Paul Jorgensen. The defendants were Glenmark Pharmaceuticals Canada Inc., represented by Mr. Gordon Jepson, and Merck & Dohme LLC, represented by Ms. Andrea Lee.

- Subject Matter: This case involved a proceeding under the Patented Medicines (Notice of Compliance) Regulations. The plaintiff sought to prevent Glenmark from entering the market with a generic version of a patented medicine before the expiry of patent rights. The matter included discovery disputes, confidentiality motions, and ongoing settlement discussions. The plaintiff moved to compel answers refused at discovery and requested protective and sealing orders. This case is ongoing.

- Date: The hearing was set on March 04, 2026.

- Venue: This was a federal case before the Federal Court in Toronto.

- Amount: No financial award was specified.